Covid: Omicron sub-variants can ‘evade antibodies’ – new vaccine receives UK approval

Date:

Share post:


In a statement, the chief executive of the MHRA (Medicines and Healthcare Regulatory Authority), Dr June Raine said: “I am pleased to announce the approval of the Moderna bivalent booster vaccine, which was found in the clinical trial to provide a strong immune response to the Omicron BA.1 variant.

“The first generation of COVID-19 vaccines being used in the UK continue to provide important protection against the disease and save lives. What this bivalent vaccine gives us is a sharpened tool in our armour against this disease.”

On the UK’s overall viral defences, Dr Raine added: “We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved COVID-19 vaccines.”

Meanwhile, Professor Sir Munir Pirmohamed said: “The virus, SARS-CoV-2, is continually evolving in order to evade the immunity provided by vaccines. This novel bivalent vaccine represents the next step in the development of vaccines to combat the virus, with its ability to lead to a broader immune response than the original vaccine.”

READ MORE: Diabetes: Golden drink shown to ‘markedly’ lower blood sugar levels



LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Related articles

Royal Family shares exciting update of historic first and meaning behind King's new cypher

The Royal Family have shared an insight to the history behind King Charles III's newly-received cypher. The...

Study shows feeling unhappy or lonely ages you more than smoking – ‘should not be ignored'

When thinking about what it takes to live a long and healthy life most of us will...

Energy crisis woes as expert reveals why UK is behind France on nuclear power

Britain is lagging behind the French when it comes to nuclear power generation, which could prove to...

Interest rates: Will interest rates go up? Bank of England responds to Sterling crisis

A higher Bank Rate often strengthens the pound as it persuades investors to demand more of the...